Back

Evaluation of the triglyceride-glucose index as a predictor of metabolic syndrome in elderly population. EVITGA-60 study

13 May 2024 (14:00 - 14:45)
Organised by: Logo
Congress Presentation Part of: Risk factors and prevention Diabetes and the Heart HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Lauren Sofia Calvo Betancourt

Colombia University Clinic, Bogota (Colombia)

5 More presentations in this session

Presentation thumbnail
Eligibility for semaglutide according to the SELECT trial in a Portuguese cohort of acute coronary syndrome
Doctor V. Lopes (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Cardiovascular diseases and type 2 diabetes mellitus: high heart failure risk and low rate contraindications to SGLT2i
Doctor V. Medovchshikov (Aktobe, KZ)
Abstract Slides Video
Presentation thumbnail
Prevalence and incidence of heart failure in patients with type 2 diabetes mellitus. Results of the prospective DIABET-IC study
Doctor R. Gonzalez-Manzanares (Cordoba, ES)
Abstract Slides Video
Presentation thumbnail
CTO recanalization in type 2 diabetic patients: procedural and long-term prognosis
Doctor A. Silva (Coimbra, PT)
Abstract Slides Video
Presentation thumbnail
Impact of dapagliflozin on exercise-induced hypertrophy: insights from a rodent model of athlete's heart
Doctor A. Olah (Budapest, HU)
Abstract Slides Video

Access the full session

Session thumbnail
Risk factors and prevention

The Event

Event poster

Heart Failure 2024

13 May 2024 14:00 CET
You may be interested in
thumbnail
Congress Presentation
The triglyceride-glucose index is a predictor for cardiovascular events and all-cause mortality in young and middle-aged patients with metabolic syndrome
thumbnail
Congress Presentation
Associations between an insulin resistance guide, the triglyceride glucose index (TyG) and subclinical atherosclerosis progression in a coronary population
thumbnail
Congress Presentation
Derivation and validation of the incremental prognostic value of increased triglyceride glucose index

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources